Kovitz Investment Group Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,004
| Closed | -$172K | – | 1300 |
|
|
2024
Q4 | $172K | Sell |
13,004
-12,452
| -49% | -$165K | ﹤0.01% | 1173 |
|
|
2024
Q3 | $314K | Buy |
25,456
+1,670
| +7% | +$20.6K | ﹤0.01% | 858 |
|
|
2024
Q2 | $308K | Buy |
23,786
+490
| +2% | +$6.34K | ﹤0.01% | 724 |
|
|
2024
Q1 | $324K | Buy |
+23,296
| New | +$324K | ﹤0.01% | 570 |
|
|
2022
Q1 | – | Sell |
-77,956
| Closed | -$1.42M | – | 449 |
|
|
2021
Q4 | $1.42M | Sell |
77,956
-158,814
| -67% | -$2.89M | 0.03% | 234 |
|
|
2021
Q3 | $3.88M | Buy |
236,770
+1,432
| +0.6% | +$23.5K | 0.08% | 173 |
|
|
2021
Q2 | $3.96M | Buy |
235,338
+157,558
| +203% | +$2.65M | 0.08% | 175 |
|
|
2021
Q1 | $1.42M | Sell |
77,780
-175
| -0.2% | -$3.2K | 0.03% | 241 |
|
|
2020
Q4 | $1.42M | Sell |
77,955
-9,784
| -11% | -$178K | 0.03% | 229 |
|
|
2020
Q3 | $1.57M | Sell |
87,739
-6,627
| -7% | -$118K | 0.04% | 211 |
|
|
2020
Q2 | $1.69M | Sell |
94,366
-8,082
| -8% | -$145K | 0.05% | 196 |
|
|
2020
Q1 | $1.56M | Sell |
102,448
-11,682
| -10% | -$177K | 0.06% | 196 |
|
|
2019
Q4 | $2.25M | Sell |
114,130
-53,741
| -32% | -$1.06M | 0.07% | 187 |
|
|
2019
Q3 | $2.89M | Sell |
167,871
-39,242
| -19% | -$675K | 0.09% | 156 |
|
|
2019
Q2 | $3.67M | Sell |
207,113
-36,476
| -15% | -$645K | 0.12% | 134 |
|
|
2019
Q1 | $4.96M | Buy |
+243,589
| New | +$4.96M | 0.16% | 97 |
|